Psilocybin for Treatment-Resistant Major Depression - Results From an Academic Phase 2b Randomized-Controlled Trial

被引：0
|
作者：
Mertens, Lea Julia [1 ]
机构：
[1] Heidelberg Univ, Cent Inst Mental Hlth, Mannheim, Germany
来源：
NEUROPSYCHOPHARMACOLOGY | 2024年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
10.2
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [1] PSILOCYBIN FOR TREATMENT-RESISTANT MAJOR DEPRESSION - RESULTS FROM AN ACADEMIC PHASE 2B RANDOMIZED-CONTROLLED TRIAL
    Mertens, Lea Julia
    Koslowski, Michael
    Brand, Manuela
    Evens, Ricarda
    Kaertner, Laura
    Majic, Tomislav
    Scharf, Dennis
    Spangemacher, Moritz
    Wolff, Max
    Gruender, Gerhard
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 462 - 463
  • [2] Randomized, controlled trial of amitriptyline versus placebo for adolescents with "treatment-resistant" major depression
    Birmaher, B
    Waterman, GS
    Ryan, ND
    Perel, J
    McNabb, J
    Balach, L
    Beaudry, MB
    Nasr, FN
    Karambelkar, J
    Elterich, G
    Quintana, H
    Williamson, DE
    Rao, U
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1998, 37 (05): : 527 - 535
  • [3] Accelerated TBS for Treatment-Resistant Depression: Results From a Randomized Controlled Trial and its Open-Label Phase
    Brunoni, Andre
    Rassi, Matheus
    Goerigk, Stephan
    Carneiro, Adriana
    Cavendish, Beatriz
    Pinto, Bianca
    Klein, Izio
    de Sousa, Juliana Pereira
    Vidal, Kallene
    Valiengo, Leandro
    Aparicio, Luana
    Borrione, Lucas
    Baptista, Mariana
    Kouvalesk, Natasha
    Benatti, Rafael
    Pelosof, Rebeca
    Silva, Valquiria
    Padberg, Frank
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 210 - 211
  • [4] Results of the First Randomized Controlled Trial of Deep Brain Stimulation in Treatment-Resistant Depression
    Richardson, R. Mark
    Ghuman, Avniel S.
    Karp, Jordan F.
    NEUROSURGERY, 2015, 77 (02) : N23 - N24
  • [5] A Randomized Controlled Trial of Ketamine for Adolescent Treatment-Resistant Depression
    Dwyer, Jennifer
    Yip, Sarah
    Sanacora, Gerard
    Bloch, Michael
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S95 - S95
  • [6] Psilocybin Assisted Therapy for Treatment-Resistant Depression: A Phase II, Randomized, Feasibility Study
    Rosenblat, Joshua
    McIntyre, Roger
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 203 - 203
  • [7] Psilocybin Assisted Therapy for Treatment-Resistant Depression: A Phase II, Randomized, Feasibility Study
    Rosenblat, Joshua
    McIntyre, Roger
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 203 - 203
  • [8] Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial
    Rush, AJ
    Marangell, LB
    Sackeim, HA
    George, MS
    Brannan, SK
    Davis, SM
    Howland, R
    Kling, MA
    Rittberg, BR
    Burke, WJ
    Rapaport, MH
    Zajecka, J
    Nierenberg, AA
    Husain, MM
    Ginsberg, D
    Cooke, RG
    BIOLOGICAL PSYCHIATRY, 2005, 58 (05) : 347 - 354
  • [9] A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression
    Nagele, Peter
    Palanca, Ben J.
    Gott, Britt
    Brown, Frank
    Barnes, Linda
    Nguyen, Thomas
    Xiong, Willa
    Salloum, Naji C.
    Espejo, Gemma D.
    Lessov-Schlaggar, Christina N.
    Jain, Nisha
    Cheng, Wayland W. L.
    Komen, Helga
    Yee, Branden
    Bolzenius, Jacob D.
    Janski, Alvin
    Gibbons, Robert
    Zorumski, Charles F.
    Conway, Charles R.
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (597)
  • [10] Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trial
    Taylor, Hugh S.
    Dong, Liying
    Haikonen, Johanna
    Oppelt, Peter
    Tamussino, Karl
    Wenzl, Rene
    Faustmann, Thomas
    Groettrup-Wolfers, Esther
    Ren, Xiaowei
    Seitz, Christian
    F&S REPORTS, 2024, 5 (02): : 189 - 196
12345